Seyhan Attila A, Alizadeh Babak N, Lundstrom Kenneth, Johnston Brian H
SomaGenics, Inc., Santa Cruz, CA 95060, USA.
Oligonucleotides. 2007 Winter;17(4):473-84. doi: 10.1089/oli.2007.0079.
RNA interference (RNAi) has recently shown promise as a mode of inhibition of slowly replicating viruses causing chronic diseases such as hepatitis C. To investigate whether RNAi is also feasible for rapidly growing RNA viruses such as alphaviruses, we tested the ability of expressed short hairpin RNAs (shRNAs) to inhibit the Semliki Forest virus (SFV), a rapidly replicating positive-strand RNA virus. Plasmids expressing shRNAs targeting SFV target sequences under the control of a human U6 promoter were introduced into BHK-21 cells. The targets included sequences encoding nonstructural (nsP1, 2, and 4) and structural (capsid) proteins as well as nonviral sequences serving as control targets. Twenty-four to 48 hours following transfection with shRNA plasmids, the cells were infected with replication-competent or replication-deficient recombinant SFV expressing green fluorescent protein (GFP) at a multiplicity of infection (MOI) of approximately 5. Viral replication was monitored by fluorescence microscopy and flow cytometry. Specific and marked reduction of viral replication was observed with shRNAs targeting nsP1 and nsP4. The degree of inhibition of the replication-deficient SFV was >or=70% over a 5-day period, a level similar to the transfection efficiency, suggesting complete inhibition of nonreplicating virus in the transfected cell population. However, only nsP1 shRNA was inhibitory against replication-competent SFV (approximately 30%-50% reduction), and this effect was transient. No inhibition was observed with control shRNAs. In contrast to the recent success of RNAi approaches for slowly growing viruses, these results illustrate the challenge of inhibiting very rapidly replicating RNA viruses by RNAi. However, the addition of RNAi approaches to other antiviral modalities might improve the response to acute infections.
RNA干扰(RNAi)最近显示出有望成为抑制导致慢性疾病(如丙型肝炎)的缓慢复制病毒的一种方式。为了研究RNAi对于快速增殖的RNA病毒(如甲病毒)是否也可行,我们测试了表达的短发夹RNA(shRNA)抑制Semliki森林病毒(SFV)的能力,SFV是一种快速复制的正链RNA病毒。将在人U6启动子控制下表达靶向SFV靶序列的shRNA的质粒导入BHK-21细胞。靶序列包括编码非结构蛋白(nsP1、2和4)和结构蛋白(衣壳)的序列以及用作对照靶标的非病毒序列。在用shRNA质粒转染24至48小时后,细胞以约5的感染复数(MOI)感染具有复制能力或复制缺陷的表达绿色荧光蛋白(GFP)的重组SFV。通过荧光显微镜和流式细胞术监测病毒复制。观察到靶向nsP1和nsP4的shRNA能特异性且显著地减少病毒复制。在5天的时间里,对复制缺陷型SFV的抑制程度≥70%,这一水平与转染效率相似,表明在转染的细胞群体中完全抑制了非复制病毒。然而,只有nsP1 shRNA对具有复制能力的SFV有抑制作用(减少约30%-50%),且这种作用是短暂的。对照shRNA未观察到抑制作用。与最近RNAi方法在缓慢生长病毒方面取得的成功相反,这些结果说明了通过RNAi抑制非常快速复制的RNA病毒所面临的挑战。然而,将RNAi方法与其他抗病毒方式相结合可能会改善对急性感染的应对。